Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Blood Donor Recruitment During Epidemic of COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04306055
Recruitment Status : Completed
First Posted : March 12, 2020
Last Update Posted : April 13, 2020
Sponsor:
Information provided by (Responsible Party):
OUYANG Jian, Guangzhou Blood Center

Brief Summary:
In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health Emergency of International Concern. The number of volunteer non-remunerated blood donors decreased because of quarantine, caring for relatives, and fear of exposure to COVID-19. Due to the blood shortage, patient blood management and cessation of elective surgery are contributing to decreased demand, but sepsis may increase requirements and significant reductions will not be possible in areas such as trauma, cancer patients, hereditary haemolytic anaemias and childbirth. Therefore, recruiting enough blood donors during the epidemic is vital for public health in China, and also worldwide. In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. The questionnaires were randomly sent to ever blood donors, and the same number of ever blood donors are coded as control.

Condition or disease Intervention/treatment Phase
Blood Donation Other: Questionnaire with precaution information Other: Experimental: Questionnaire without precaution information Not Applicable

Detailed Description:

In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not.

Information of precautions of blood donation during epidemic included taking donor's temperature and enhancing hand disinfection before donation etc.

The questionnaires were randomly sent to ever blood donors, and at the same day, equal number of ever blood donors as the ones who filled the questionnaire are coded as control.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 19491 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China
Actual Study Start Date : March 13, 2020
Actual Primary Completion Date : March 13, 2020
Actual Study Completion Date : April 3, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Questionnaire with precaution information
Questionnaire in this group includes information about precaution of blood donation during epidemic of COVID-19.
Other: Questionnaire with precaution information
Ever blood donors in this group would receive a questionnaire which includes some information about how donors can donate safely and how blood center will protect the blood donors during the epidemic of COVID-19.

Experimental: Questionnaire without precaution information
Questionnaire in this group dose not include information about precaution of blood donation during epidemic of COVID-19.
Other: Experimental: Questionnaire without precaution information
Ever blood donors in this group would receive a questionnaire which dose not include the information above.

No Intervention: No questionnaire group
Ever donors in this group would not receive the questionnaire.



Primary Outcome Measures :
  1. Differences of attitude about blood donation towards different questionnaires [ Time Frame: 1 day ]
    Compare participants' intention of blood donation after they read different information in the questionnaire.


Secondary Outcome Measures :
  1. Rates of blood donation during 3 weeks [ Time Frame: 3 weeks ]
    Blood donation rate of 3 groups will be followed



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Blood donors whose last donation were between 1 Feb to 31 March, 2019.

Exclusion Criteria:

  • Blood donors whose blood test results were positive. Blood donors who were aged above 60. Blood donors whose cell phone number was obviously invalid.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04306055


Locations
Layout table for location information
China, Guangdong
Guangzhou Blood Center
Guangzhou, Guangdong, China, 510095
Sponsors and Collaborators
Guangzhou Blood Center
Layout table for additonal information
Responsible Party: OUYANG Jian, Investigator, Guangzhou Blood Center
ClinicalTrials.gov Identifier: NCT04306055    
Other Study ID Numbers: Blood donor recruitment
First Posted: March 12, 2020    Key Record Dates
Last Update Posted: April 13, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No